This is an automated archive made by the Lemmit Bot.
The original was posted on /r/technology by /u/wsj on 2024-02-01 19:47:15.
Five years ago, 23andMe was one of the hottest tech startups in the world. Now, the DNA-testing company is virtually worthless. Its valuation has crashed 98% from its peak and Nasdaq has threatened to delist its sub-$1 stock.
While CEO Anne Wojcicki isn’t giving up on her company, she has stumbled in pursuit of her goal to transform 23andMe from a supplier of basic ancestry and health data into a comprehensive healthcare company that develops drugs, offers medical care and sells subscription health reports
I’m Rolfe Winkler, digital health reporter for The Wall Street Journal. I’ve interviewed more than 50 current and former 23andMe executives, employees, contractors, board members and others familiar with the company and its CEO. Ask me anything
Proof: https://www.reddit.com/media?url=https%3A%2F%2Fi.redd.it%2F9qz8jq43u0gc1.jpeg
Note: All WSJ stories linked are free to read.